Sunday, November 22, 2026

Funding · Morrisville, NC

iORGANBIO lands Mitsui Chemicals investment

The Morrisville biotech and the Japanese materials maker will combine an AI-run cell lab with InnoCell culture plates to make more consistent human cells and organoids.

·

iORGANBIO lands Mitsui Chemicals investment

iORGANBIO, a Morrisville biotechnology company, announced on Nov. 10 that it has received an investment from Mitsui Chemicals through 321Catalyst, the Japanese chemical maker's corporate venture capital fund. The amount was not disclosed.

Founded in July 2024 and led by CEO Daniel Delubac, iORGANBIO designs and manufactures human cells and organoids for drug discovery and regenerative medicine. Its platform links AI, single-cell analysis and robotics in a closed-loop autonomous lab built to produce target cells with a high degree of uniformity and reproducibility.

Mitsui Chemicals will contribute its materials design work, including its InnoCell cell culture plates. The companies aim to improve cell and organoid quality and to make cell types that have been hard to manufacture, and they plan to explore drug discovery tools, including efficacy and safety testing, that could complement or serve as alternatives to animal testing.

"We are thrilled to announce our growing relationship with Mitsui Chemicals," said Delubac. "We are excited to partner with iORGANBIO in contributing to greater efficiency in drug discovery and advancements in cell therapy and regenerative medicine," said Shunsuke Fujii, PhD, GM of New Business Incubation Center, Mitsui Chemicals.

Share this storyXLinkedInFacebookWhatsAppEmail

About this story

By Sotwire Desk. Written by Sotwire Desk from the sources below. Not a company attestation.

Desk reportedSotwire Desk. Written by a named Sotwire editor from the sources cited below. Not a company attestation. Sotwire corrects errors publicly.

Key facts

Company
iORGANBIO
Place
Morrisville, NC
Section
Funding
Announced
Record
Desk reported
Company source
Sotwire Desk
Investor
Mitsui Chemicals, via 321Catalyst CVC fund
Amount
Not disclosed
Founded
July 2024
CEO
Daniel Delubac, PhD

Key events

  1. iORGANBIO founded
  2. Mitsui Chemicals investment announced

Sources

  1. iORGANBIO and Mitsui Chemicals Collaborate to Advance AI-Driven Human Cell and Organoid Manufacturing · GlobeNewswire / iORGANBIO · accessed 2026-11-16
  2. Mitsui Chemicals Invests in iOrganBio, Developer of a Human Cell Design and Manufacturing Platform · Mitsui Chemicals · accessed 2026-11-16

North Carolina business, in one useful email.

Get launches, hires, funding, and project wins from across the state, with the Triangle at the center. Each story names the company source who stood behind it.

By subscribing, you agree to receive the Sotwire newsletter. We will not sell your email address. Newsletter details.